Service & Quality
As part of our commitment to providing a true end-to-end technical platform for our clients, the DMPK Unit works closely with chemistry, biology and pharmacology for effective lead selection during discovery, and with toxicology and GLP bioanalysis for regulatory support during drug development. As an organization, we are fully aligned in our goal of providing high-quality service and data to enable our clients to move seamlessly from discovery through NDA filing.
Dedicated Global Facility
DMPK scientists at the Laboratory Testing Division perform a wide range of IND- and NDA-enabling services from four state-of-the-art facilities across our global operations. Headquartered in Shanghai, China with a dedicated bioanalytical and DMPK/ADME facility in the northeastern United States, the DMPK service maintains full compliance across international regulatory bodies, which enables us to provide regional support for our clients across the world.
Track Record of Success
The DMPK service has secured a diverse client base comprising nearly all big pharma companies, and over 300 small- to mid-sized biopharma, virtual pharma, nonprofit organizations and academic institutions around the world. DMPK is also integrated within the various other services at the Laboratory Testing Division, which affords us the ability to handle your project with unprecedented efficiency, maintaining industry-leading turnaround times to accelerate your discovery and development efforts.